SOD3 R231G polymorphism associated with coronary artery disease and myocardial infarction. The Ludwigshafen Risk and Cardiovascular Health (LURIC) study |
| |
| Authors: | Tanja B. Grammer Wilfried Renner Michael M. Hoffmann Markus Kleber Brigitte M. Winkelhofer-Roob Bernhard O. Boehm |
| |
| Affiliation: | 1. Synlab Center of Laboratory Diagnostics Heidelberg, Heidelberg, Germany;2. Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Austriatanja.grammer@synlab.de;4. Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Austria;5. Division of Clinical Chemistry, Department of Medicine, University Medical Center, Freiburg, Germany;6. The Human Nutrition and Metabolism Research and Training Center Graz, Karl-Franzens University, Graz, Austria;7. Division of Endocrinology and Diabetes, Department of Medicine, Ulm University, Germany |
| |
| Abstract: | ![]()
This study examined the superoxide dismutase 3 (SOD3) R231G polymorphism in relation to the severity of coronary artery disease (CAD) and the risk of myocardial infarction (MI) in 3211 individuals; 94.4% of study participants were homozygous for SOD3 231RR and 5.5% were heterozygous for SOD3 231RG. The odds ratios of the RG and GG genotype (adjusted for age, gender and for conventional cardiovascular risk factors) were 2.02 (95% CI, 1.23–3.33, p=0.005) for the highest vs the lowest Friesinger coronary score and 1.40 (95% CI, 1.02–1.92, p=0.037) for MI, respectively. Further the SOD3 RG and GG genotype was associated with lower alpha-tocopherol levels than the wild type SOD3 RR genotype. It is concluded that the SOD3 231RG and GG genotype is associated with lower alpha-tocopherol levels and the severity of CAD and the risk of MI. |
| |
| Keywords: | Coronary artery disease myocardial infarction superoxide dismutase atherosclerosis polymorphism alpha-tocopherol |
|
|
